Evidence map›Paper›PMID 39815815›Full record

ArticleHaematologica2025

Manganese overload as a co-factor of neurological symptoms in a patient with sclerosing cholangitis due to Langerhans cell histiocytosis.

Jerome Razanamahery, Ahmed Idbaih, Matthias Papo, Fabien Robelin, Jean-Francois Emile, Sylvain Audia, Bernard Bonnotte, Julien Haroche

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jerome RazanamaheryDepartment of internal medicine and clinical immunology. French Competence Center for Histiocytosis. Dijon university hospital. Dijon France. jerome.razanamahery@chu-dijon.fr.
Ahmed IdbaihSorbonne Université, AP-HP, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, DMU Neurosciences, Service de Neuro-Oncologie-Institut de Neurologie, F-75013, Paris, France.
Matthias PapoSorbonne University, Internal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, Pitié-Salp trière.
Fabien RobelinDepartment of neuroradiology. Dijon university hospital. Dijon France.
Jean-Francois EmileDepartment of pathology. Ambroise Pare Hospital, Paris. France.
Sylvain AudiaDepartment of internal medicine and clinical immunology. French Competence Center for Histiocytosis. Dijon university hospital. Dijon France.
Bernard BonnotteDepartment of internal medicine and clinical immunology. French Competence Center for Histiocytosis. Dijon university hospital. Dijon France.
Julien HarocheSorbonne University, Internal Medicine Department 2, Institut E3M, French Reference Centre for Histiocytosis, Pitié-Salp trière.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39815815
PMCPMC12050918

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.